farnesol has been researched along with squalestatin 1 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gibbs, JB; Kohl, NE; Lingham, RB; Mosser, SD; Oliff, A; Pompliano, DL; Rands, E; Scolnick, EM; Singh, SB | 1 |
| Chambers, C; Keller, RK; Ness, GC; Zhao, Z | 1 |
| Arison, BH; Bansal, VS; Bergstrom, JD; Bostedor, RG; Germershausen, JI; Karkas, JD; Kurtz, MM; Vaidya, S | 1 |
| Bansal, VS; Bergstrom, JD; Bostedor, R; Kurtz, MM; Vaidya, S | 1 |
| Bach, TJ; Hartmann, MA; Hemmerlin, A; Wentzinger, L | 1 |
| Cuko, L; Duniec-Dmuchowski, Z; Fallon, JK; Kocarek, TA; Pant, A; Peraino, NJ; Rondini, EA; Smith, PC; Westrick, JA; Wilson, EM | 1 |
6 other study(ies) available for farnesol and squalestatin 1
| Article | Year |
|---|---|
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Brain; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cattle; Cell Line, Transformed; Farnesol; Gene Expression Regulation; Genes, ras; Kinetics; Maleates; Mice; Organophosphonates; Organophosphorus Compounds; Protein Processing, Post-Translational; Transferases; Tricarboxylic Acids | 1993 |
Farnesol is not the nonsterol regulator mediating degradation of HMG-CoA reductase in rat liver.
Topics: Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Cycloheximide; Enzyme Inhibitors; Farnesol; Farnesyl-Diphosphate Farnesyltransferase; Half-Life; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Liver; Lovastatin; Male; Mevalonic Acid; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Time Factors; Tricarboxylic Acids | 1996 |
Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol.
Topics: Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, High Pressure Liquid; Dicarboxylic Acids; Dogs; Farnesol; Farnesyl-Diphosphate Farnesyltransferase; Magnetic Resonance Spectroscopy; Models, Chemical; Rats; Spectrophotometry, Ultraviolet; Tricarboxylic Acids | 1997 |
Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Chromatography, Gas; Chromatography, High Pressure Liquid; Dicarboxylic Acids; Enzyme Inhibitors; Farnesol; Farnesyl-Diphosphate Farnesyltransferase; Female; In Vitro Techniques; Kidney; Liver; Mevalonic Acid; Mice; Tricarboxylic Acids | 1998 |
Metabolism of farnesyl diphosphate in tobacco BY-2 cells treated with squalestatin.
Topics: Aphidicolin; Bridged Bicyclo Compounds, Heterocyclic; Carbon Radioisotopes; Cell Cycle; Cell Division; Cell Line; Coenzymes; Farnesol; Farnesyl-Diphosphate Farnesyltransferase; G1 Phase; Hydroxymethylglutaryl CoA Reductases; Mitochondria; Nicotiana; Plants, Toxic; Polyisoprenyl Phosphates; Radioisotope Dilution Technique; Sesquiterpenes; Sodium Acetate; Sterols; Transcription, Genetic; Tricarboxylic Acids; Ubiquinone | 2000 |
Negative Regulation of Human Hepatic Constitutive Androstane Receptor by Cholesterol Synthesis Inhibition: Role of Sterol Regulatory Element Binding Proteins.
Topics: Animals; Anticholesteremic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Cholesterol; Constitutive Androstane Receptor; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2D6; Farnesol; Gene Expression Regulation, Enzymologic; Gene Knockdown Techniques; Hepatocytes; Humans; Liver; Mice; Pravastatin; Rats; Sterol Regulatory Element Binding Proteins; Tricarboxylic Acids | 2021 |